Franco N.
- Country
- Italy
- Department
- Divisione di Oncologia Medica Urogenitale e Cervico facciale
Research Overview
- A Phase 3 Study of JNJ-78278343 and Docetaxel Versus Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
- Phase 3 Study of Enfortumab Vedotin and Pembrolizumab Versus Chemotherapy in Untreated Locally Advanced or Metastatic Urothelial Cancer
Data & Insights
Has run more than one trial at 306 of 574 partner sites.
Specializations
Urological Oncology
The investigator specializes in treating various forms of urological cancers, with particular emphasis on bladder cancer and urothelial carcinoma. Their research encompasses both muscle-invasive and metastatic disease states.
- Muscle-invasive bladder cancer treatment
- Advanced urothelial carcinoma management
- Novel therapeutic combinations for bladder cancer
Renal Cancer Research
The investigator focuses on advancing treatment options for renal cell carcinoma, particularly in its metastatic forms. Their work includes studies of innovative combination therapies and targeted treatments.
- Metastatic renal cell carcinoma therapy
- Immunotherapy combinations
- Papillary renal cell carcinoma treatment
Prostate Cancer Treatment
The investigator conducts research in castration-resistant prostate cancer and explores novel therapeutic approaches for various stages of prostate cancer progression.
- Metastatic castration-resistant disease
- Hormone therapy resistance
- Combination treatment strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.